This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Przyklenk, K. Articles by Whittaker, P. Search for Related Content PubMed PubMed Citation Articles by Przyklenk, K. Articles by Whittaker, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Animal models of human disease Ischemic biology - basic studies Acute coronary syndromes Acute myocardial infarction Platelets Receptor pharmacology

(Circulation. 2000;102:88.)
© 2000 American Heart Association, Inc.

Basic Science Reports

Brief Antecedent Ischemia Enhances Recombinant Tissue Plasminogen Activator–Induced Coronary Thrombolysis by Adenosine-Mediated Mechanism

Karin Przyklenk, PhD; Peter Whittaker, PhD

From the Heart Institute, Good Samaritan Hospital, and the Department of Medicine, University of Southern California, Los Angeles.

Correspondence to Karin Przyklenk, PhD, Heart Institute/Research, Good Samaritan Hospital, 1225 Wilshire Blvd, Los Angeles, CA 90017-2395. E-mail karinp{at}dnamail.com

Background—Clinical studies have implicated preinfarct angina (brief antecedent ischemia/reperfusion [I/R]) as a predictor of more rapid thrombolysis and lower rates of reocclusion. However, the effects of antecedent ischemia on the efficacy of thrombolysis have not been rigorously assessed. Using a canine model of coronary thrombosis, we aimed to (1) reproduce these clinical findings and (2) determine whether release of adenosine (a potent inhibitor of platelet aggregation via stimulation of platelet A₂ receptors) during brief I/R contributes to this improved patency.

Methods and Results—To address our first objective, we compared the time required to achieve lysis with recombinant tissue plasminogen activator and patency during the first 2 hours after lysis in dogs in which 1-hour thrombotic occlusion was preceded by brief I/R (10-minute coronary occlusion/10-minute reperfusion) versus 20-minute uninterrupted perfusion (controls). Time to lysis was accelerated in the I/R group versus the control group (11±1 versus 35±6 minutes, P=0.004). In addition, the duration of subsequent reocclusion was reduced (17±12 versus 30±11 minutes), and the area of the flow-time profile (normalized to baseline flowx120 minutes) was increased (64±12% versus 35±7%, P=0.04) in the I/R cohort. The protocol was then repeated, but all dogs were pretreated with the adenosine A₂/A₁ antagonist CGS 15943 (CGS, 1.5 mg/kg). Time to lysis (38 versus 39 minutes) and subsequent patency were comparable in the CGS+control group versus the CGS+I/R group.

Conclusions—Brief antecedent I/R enhances the efficacy of coronary thrombolysis in this canine model, which is due, at least in part, to an adenosine-mediated mechanism.

Key Words: ischemia • thrombolysis • adenosine • myocardial infarction

This article has been cited by other articles:

				E. A. Amsterdam and S. Schaefer Ischemic preconditioning in coronary heart disease: a therapeutic golden fleece? J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1515 - 1516. [Full Text] [PDF]

				D. M. YELLON and J. M. DOWNEY Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology Physiol Rev, October 1, 2003; 83(4): 1113 - 1151. [Abstract] [Full Text] [PDF]

				R. A Kloner, M. T Speakman, and K. Przyklenk Ischemic preconditioning: a plea for rationally targeted clinical trials Cardiovasc Res, August 15, 2002; 55(3): 526 - 533. [Full Text] [PDF]